PL93689B1 - - Google Patents

Download PDF

Info

Publication number
PL93689B1
PL93689B1 PL1975177303A PL17730375A PL93689B1 PL 93689 B1 PL93689 B1 PL 93689B1 PL 1975177303 A PL1975177303 A PL 1975177303A PL 17730375 A PL17730375 A PL 17730375A PL 93689 B1 PL93689 B1 PL 93689B1
Authority
PL
Poland
Prior art keywords
virus
influenza
components
vaccine
immunizing
Prior art date
Application number
PL1975177303A
Other languages
English (en)
Polish (pl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL93689B1 publication Critical patent/PL93689B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
PL1975177303A 1974-01-14 1975-01-13 PL93689B1 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (en:Method) 1974-01-14 1974-01-14

Publications (1)

Publication Number Publication Date
PL93689B1 true PL93689B1 (en:Method) 1977-06-30

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1975177303A PL93689B1 (en:Method) 1974-01-14 1975-01-13

Country Status (27)

Country Link
JP (2) JPS58407B2 (en:Method)
AT (1) AT345449B (en:Method)
AU (1) AU500250B2 (en:Method)
BE (1) BE824372A (en:Method)
CA (1) CA1049406A (en:Method)
CH (1) CH589453A5 (en:Method)
CS (1) CS191254B2 (en:Method)
DD (1) DD116239A5 (en:Method)
DE (1) DE2500785B2 (en:Method)
DK (1) DK140003B (en:Method)
ES (1) ES433759A1 (en:Method)
FI (1) FI54053C (en:Method)
FR (1) FR2257305B1 (en:Method)
GB (1) GB1498261A (en:Method)
HK (1) HK56380A (en:Method)
HU (1) HU173920B (en:Method)
IE (1) IE40794B1 (en:Method)
IL (1) IL46426A (en:Method)
MY (1) MY8100204A (en:Method)
NL (1) NL166622C (en:Method)
NO (1) NO143128C (en:Method)
PH (1) PH14458A (en:Method)
PL (1) PL93689B1 (en:Method)
SE (1) SE427238B (en:Method)
SU (1) SU616997A3 (en:Method)
YU (1) YU41289B (en:Method)
ZA (1) ZA75259B (en:Method)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
JPH0688911B2 (ja) * 1985-06-06 1994-11-09 国立予防衛生研究所長 インフルエンザワクチン及びその製造方法
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
CA2627971A1 (en) * 2005-11-01 2007-05-10 Novartis Vaccines And Diagnostics Gmbh & Co Kg. Cell-derived viral vaccines with low levels of residual cell dna by beta-propiolactone treatment
EP2192917B1 (en) * 2007-08-28 2014-01-29 Baxter International Inc. Method for producing viral vaccines
JP6373376B2 (ja) 2013-11-15 2018-08-15 ノバルティス アーゲー 残留細胞培養不純物の除去

Also Published As

Publication number Publication date
GB1498261A (en) 1978-01-18
AT345449B (de) 1978-09-11
CA1049406A (en) 1979-02-27
NO750031L (en:Method) 1975-08-11
NL166622C (nl) 1981-09-15
SU616997A3 (ru) 1978-07-25
DE2500785A1 (de) 1975-07-31
PH14458A (en) 1981-07-29
IE40794L (en) 1975-07-14
YU5875A (en) 1984-04-30
DK1475A (en:Method) 1975-09-01
NL7500301A (nl) 1975-07-16
HU173920B (hu) 1979-09-28
CS191254B2 (en) 1979-06-29
NL166622B (nl) 1981-04-15
YU41289B (en) 1987-02-28
JPS56127319A (en) 1981-10-06
HK56380A (en) 1980-10-16
FR2257305A1 (en:Method) 1975-08-08
DK140003C (en:Method) 1979-10-29
CH589453A5 (en:Method) 1977-07-15
JPS58407B2 (ja) 1983-01-06
DE2500785B2 (de) 1980-01-03
IL46426A0 (en) 1975-04-25
FR2257305B1 (en:Method) 1982-03-19
FI750014A7 (en:Method) 1975-07-15
DE2500785C3 (en:Method) 1980-09-11
SE7500130L (en:Method) 1975-07-15
JPS6035326B2 (ja) 1985-08-14
FI54053C (fi) 1978-10-10
JPS50100224A (en:Method) 1975-08-08
ATA21475A (de) 1978-01-15
ZA75259B (en) 1976-08-25
DD116239A5 (en:Method) 1975-11-12
MY8100204A (en) 1981-12-31
AU500250B2 (en) 1979-05-17
BE824372A (fr) 1975-07-14
SE427238B (sv) 1983-03-21
AU7730575A (en) 1976-07-15
NO143128C (no) 1980-12-29
FI54053B (fi) 1978-06-30
NO143128B (no) 1980-09-15
IE40794B1 (en) 1979-08-15
DK140003B (da) 1979-06-05
ES433759A1 (es) 1977-02-16
IL46426A (en) 1978-01-31

Similar Documents

Publication Publication Date Title
Morein et al. Effective subunit vaccines against an enveloped animal virus
Johansson et al. Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection
JP5258127B2 (ja) インフルエンザワクチン
JP2812352B2 (ja) 核酸製剤
AU701024B2 (en) Method for preparing an influenza virus, antigens obtained and applications thereof
US4009258A (en) Influenza vaccine containing a recombinant, antigenically hybridized virus and method of using the same
CN102781469A (zh) 用于生产流感疫苗的方法
CN103096922A (zh) 用于治疗流行性感冒的组合物和方法
JP2002532435A (ja) Ｒｓｖサブユニット成分およびインフルエンザウイルス調製物を含む多価免疫原性組成物
US4064232A (en) Process for isolating the immunogenic components of influenza viruses
PL93689B1 (en:Method)
CN103228293A (zh) 用于在哺乳动物中预防和治疗金迪普拉病毒感染的疫苗制剂
US4140762A (en) Influenza sub-unit vaccine
EP2822585B1 (en) Improved vaccination against influenza
Park et al. Preparation and immunogenicity of influenza virus-like particles using nitrocellulose membrane filtration
Hocart et al. Preparation and characterization of a purified influenza virus neuraminidase vaccine
Virelizier et al. The role of humoral immunity in host defence against influenza A infection in mice
Doherty et al. Recombinant vaccinia viruses and the development of immunization strategies using influenza virus
EP1652914A1 (en) Virosome particles comprising antigens from influenza virus and Hepatitis B virus
RU2193065C2 (ru) Конструкция днк (варианты), днк-вектор, иммуногенная композиция против вируса гриппа, способ индукции иммунного ответа, вакцина и способ вакцинации
Hobson The strain-specific serological activity of a non-haemagglutinating fraction of influenza viruses
Hurwitz et al. Influenza-specific suppression: contribution of major viral proteins to the generation and function of T suppressor cells.
CA1270438A (en) Influenza vaccine
EP3858380A1 (en) Inactivated whole-virus influenza vaccine and method for preparing same
EP1802746B1 (en) Virosome particles comprising antigens from influenza virus and hepatitis b virus